Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 3/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.54 |
| ▸ | HTT | P42858 | 1/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | CASP1 | P29466 | 1/20 | 0.43 |
| ▸ | CASP7 | P55210 | 1/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5499784 | 0.84 | POLB (0.66) | POLBSMN1; SMN2HTTL3MBTL1MAPT | |
| SCHEMBL1538426 | 0.84 | POLB (0.66) | POLBSMN1; SMN2HTTL3MBTL1MAPT | |
| SCHEMBL7951946 | 0.84 | POLB (0.66) | POLBSMN1; SMN2HTTL3MBTL1MAPT | |
| SCHEMBL15084846 | 0.81 | POLB (0.62) | POLBSMN1; SMN2HTTL3MBTL1MAPT | |
| SCHEMBL8293964 | 0.81 | POLB (0.67) | POLBSMN1; SMN2HTTL3MBTL1MAPT | |
| SCHEMBL10922468 | 0.79 | POLB (0.60) | POLBSMN1; SMN2HTTL3MBTL1MAPT | |
| SCHEMBL31537602 | 0.79 | POLB (0.60) | POLBSMN1; SMN2HTTL3MBTL1MAPT | |
| SCHEMBL31537583 | 0.79 | POLB (0.60) | POLBSMN1; SMN2HTTL3MBTL1MAPT | |
| SCHEMBL15082395 | 0.79 | POLB (0.60) | POLBSMN1; SMN2HTTL3MBTL1MAPT | |
| SCHEMBL7058049 | 0.79 | BRD4 (0.60) | POLBSMN1; SMN2L3MBTL1ALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220233481-A1 | METHODS OF REDUCING SYMPTOMS OF OPIOID WITHDRAWAL SYNDROME AND RISK OF RELAPSE TO DRUG SEEKING | UTI LIMITED PARTNERSHIP (CA) | 2022-07-28 | — | — | US | disclosed |
| US-11298569-B2 | Methods and compositions for modulating opioid withdrawal symptoms | UTI LIMITED PARTNERSHIP (CA) | 2022-04-12 | — | — | US | disclosed |
| US-20190351008-A1 | METHODS AND COMPOSITIONS FOR MODULATING OPIOID WITHDRAWAL SYMPTOMS | UTI LIMITED PARTNERSHIP (CA) | 2019-11-21 | — | — | US | disclosed |
| EP-1581532-B1 | PYRAZOLO¬3,4-B PYRIDINE COMPOUNDS, AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS | GLAXO GROUP LTD (GB) | 2010-04-28 | — | — | EP | disclosed |